{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:13:15Z","timestamp":1785881595099,"version":"3.56.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fibromyalgia (FM) as a prototypical nociplastic pain condition displays a difficult therapeutic situation in many cases. Given the promising data on the effect of vitamin B12 in improving pain and cognitive functions in various nociplastic pain conditions, we aimed to determine the efficacy of 1000 mcg daily dose of oral vitamin B12 on the symptom severity and psychological profile of FM patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This open-label, pre-post study was performed on FM patients whose diagnoses were confirmed by a rheumatologist based on the 2016 American College of Rheumatology (ACR). Patients were instructed to take a daily dose of 1000mcg vitamin B12 for fifty days. Outcome measures including the Revised Fibromyalgia Impact Questionnaire (FIQR), Hospital Anxiety and Depression Scale (HADS), 12-item Short-Form health survey (SF-12), and pain Visual Analog Scale (pain-VAS) were fulfilled by patients before and after the treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 30 eligible patients, 28 patients completed the study protocol. Patients were female with a mean age of 47.50\u2009\u00b1\u20098.47\u00a0years. FIQR scores in all domains improved significantly after treatment (total FIQR: 49.8\u2009\u00b1\u200921.86 vs 40.00\u2009\u00b1\u200918.36, <jats:italic>p<\/jats:italic> value\u2009&lt;\u20090.01; function: 13.17\u2009\u00b1\u20097.33 vs 10.30\u2009\u00b1\u20095.84, <jats:italic>p<\/jats:italic> value: 0.01; overall: 10.32\u2009\u00b1\u20096.22 vs 8.25\u2009\u00b1\u20096.22, <jats:italic>p<\/jats:italic> value: 0.03; symptoms: 26.30\u2009\u00b1\u200910.39 vs 21.44\u2009\u00b1\u20098.58, <jats:italic>p<\/jats:italic> value\u2009&lt;\u20090.01). Vitamin B12 also improved anxiety scores from 9.33\u2009\u00b1\u20094.30 to 7.70\u2009\u00b1\u20093.60, <jats:italic>p<\/jats:italic> value: 0.01. Depression, pain-VAS, and SF-12 didn\u2019t improve following the treatment. The Generalized estimating equations (GEE) analysis showed the improvement in total FIQR score is not cofounded by the improvement of anxiety and patients\u2019 baseline characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study showed a short course of sublingual vitamin B12, 1000 mcg daily, significantly improves the severity of FM and anxiety score. We postulate that vitamin B12 has a strong potential to consider, at least, as adjunctive therapy of FM.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study protocol was approved by the ethics committee of Guilan University of Medical Sciences (IR.GUMS.REC.1400.197) in accordance with the World Medical Association\u2019s code of ethics (Declaration of Helsinki, revised in Brazil 2013), and registered at an ICMJE and WHO recognized registry of clinical trials (<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.irct.ir\">www.irct.ir<\/jats:ext-link>) on 28\/08\/2021 (registration number: IRCT20200920048782N1).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41927-022-00282-y","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T01:04:19Z","timestamp":1661994259000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effect of vitamin B12 on the symptom severity and psychological profile of fibromyalgia patients; a prospective pre-post study"],"prefix":"10.1186","volume":"6","author":[{"given":"Faeze","family":"Gharibpoor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9033-1756","authenticated-orcid":false,"given":"Banafsheh","family":"Ghavidel-Parsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazila","family":"Sattari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-1838","authenticated-orcid":false,"given":"Ali","family":"Bidari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Nejatifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Montazeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,1]]},"reference":[{"issue":"3","key":"282_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3344\/kjp.2015.28.3.169","volume":"28","author":"B Ghavidel-Parsa","year":"2015","unstructured":"Ghavidel-Parsa B, Bidari A, Maafi AA, Ghalebaghi B. The iceberg nature of fibromyalgia burden: the clinical and economic aspects. Korean J Pain. 2015;28(3):169.","journal-title":"Korean J Pain"},{"issue":"3","key":"282_CR2","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","volume":"152","author":"CJ Woolf","year":"2011","unstructured":"Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3):S2\u201315.","journal-title":"Pain"},{"issue":"12","key":"282_CR3","doi-asserted-by":"publisher","first-page":"e0225836","DOI":"10.1371\/journal.pone.0225836","volume":"14","author":"M L\u00f3pez-Ruiz","year":"2019","unstructured":"L\u00f3pez-Ruiz M, Losilla JM, Monfort J, Portell M, Guti\u00e9rrez T, Poca V, et al. Central sensitization in knee osteoarthritis and fibromyalgia: Beyond depression and anxiety. PLoS ONE. 2019;14(12):e0225836.","journal-title":"PLoS ONE"},{"key":"282_CR4","first-page":"741746","volume":"2012","author":"S Becker","year":"2012","unstructured":"Becker S, Schweinhardt P. Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems. Pain Res Treat. 2012;2012:741746.","journal-title":"Pain Res Treat"},{"issue":"2","key":"282_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/biomedicines5020015","volume":"5","author":"G Littlejohn","year":"2017","unstructured":"Littlejohn G, Guymer E. Modulation of NMDA receptor activity in fibromyalgia. Biomedicines. 2017;5(2):15.","journal-title":"Biomedicines"},{"issue":"2\u20133","key":"282_CR6","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejphar.2008.11.059","volume":"602","author":"K-L Hung","year":"2009","unstructured":"Hung K-L, Wang C-C, Huang C-Y, Wang S-J. Cyanocobalamin, vitamin B12, depresses glutamate release through inhibition of voltage-dependent Ca2+ influx in rat cerebrocortical nerve terminals (synaptosomes). Eur J Pharmacol. 2009;602(2\u20133):230\u20137.","journal-title":"Eur J Pharmacol"},{"key":"282_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/424651","volume":"2013","author":"M Zhang","year":"2013","unstructured":"Zhang M, Han W, Hu S, Xu H. Methylcobalamin: a potential vitamin of pain killer. Neural Plast. 2013;2013:1\u20136.","journal-title":"Neural Plast"},{"issue":"1","key":"282_CR8","doi-asserted-by":"publisher","first-page":"E45","DOI":"10.36076\/ppj\/2019.22.E45","volume":"22","author":"S Buesing","year":"2019","unstructured":"Buesing S, Costa M, Schilling JM, Moeller-Bertram T. Vitamin B12 as a treatment for pain. Pain Physician. 2019;22(1):E45\u201352.","journal-title":"Pain Physician"},{"issue":"1","key":"282_CR9","first-page":"R359","volume":"273","author":"M Ikeda","year":"1997","unstructured":"Ikeda M, Azuma S, Inoue S. Vitamin B12 enhances GABA content but reduces glutamate content in the rat suprachiasmatic nucleus. Am J Physiol. 1997;273(1):R359\u201363.","journal-title":"Am J Physiol"},{"issue":"7","key":"282_CR10","first-page":"324","volume":"62","author":"H Hosseinzadeh","year":"2012","unstructured":"Hosseinzadeh H, Moallem SA, Moshiri M, Sarnavazi MS, Etemad L. Anti-nociceptive and anti-inflammatory effects of cyanocobalamin (vitamin B12) against acute and chronic pain and inflammation in mice. Arzneimittelforschung. 2012;62(7):324\u20139.","journal-title":"Arzneimittelforschung"},{"issue":"Suppl 5","key":"282_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/09637480802406153","volume":"60","author":"A Talaei","year":"2009","unstructured":"Talaei A, Siavash M, Majidi H, Chehrei A. Vitamin B12 may be more effective than nortriptyline in improving painful diabetic neuropathy. Int J Food Sci Nutr. 2009;60(Suppl 5):71\u20136.","journal-title":"Int J Food Sci Nutr"},{"issue":"3","key":"282_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/tbj.12951","volume":"24","author":"A Campbell","year":"2018","unstructured":"Campbell A, Heydarian R, Ochoa C, Dwivedi AK, Nahleh ZA. Single arm phase II study of oral vitamin B12 for the treatment of musculoskeletal symptoms associated with aromatase inhibitors in women with early stage breast cancer. Breast J. 2018;24(3):260\u20138.","journal-title":"Breast J"},{"issue":"5","key":"282_CR13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s00296-016-3454-y","volume":"36","author":"JF de Carvalho","year":"2016","unstructured":"de Carvalho JF, Naiana D, Silva F. Serum levels of vitamin B12 (cobalamin) in fibromyalgia. Rheumatol Int. 2016;36(5):741.","journal-title":"Rheumatol Int"},{"issue":"4","key":"282_CR14","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/014107689909200405","volume":"92","author":"LC Heap","year":"1999","unstructured":"Heap LC, Peters TJ, Wessely S. Vitamin B status in patients with chronic fatigue syndrome. J R Soc Med. 1999;92(4):183\u20135.","journal-title":"J R Soc Med"},{"key":"282_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ebiom.2019.07.031","volume":"46","author":"M Clos-Garcia","year":"2019","unstructured":"Clos-Garcia M, Andr\u00e9s-Marin N, Fern\u00e1ndez-Eulate G, Abecia L, Lav\u00edn JL, van Liempd S, et al. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine. 2019;46:499\u2013511.","journal-title":"EBioMedicine"},{"issue":"4","key":"282_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3109\/03009749709105320","volume":"26","author":"B Regland","year":"1997","unstructured":"Regland B, Andersson M, Abrahamsson L, Bagby J, Dyrehag LE, Gottfries CG. Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand J Rheumatol. 1997;26(4):301\u20137.","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"282_CR17","doi-asserted-by":"publisher","first-page":"e0124648","DOI":"10.1371\/journal.pone.0124648","volume":"10","author":"B Regland","year":"2015","unstructured":"Regland B, Forsmark S, Halaouate L, Matousek M, Peilot B, Zachrisson O, et al. Response to vitamin B12 and folic acid in myalgic encephalomyelitis and fibromyalgia. PLoS ONE. 2015;10(4):e0124648.","journal-title":"PLoS ONE"},{"key":"282_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2174\/1874205X01307010044","volume":"7","author":"EU Syed","year":"2013","unstructured":"Syed EU, Wasay M, Awan S. Vitamin B12 supplementation in treating major depressive disorder: a randomized controlled trial. Open Neurol J. 2013;7:44\u20138.","journal-title":"Open Neurol J"},{"issue":"10","key":"282_CR19","first-page":"e11169e","volume":"12","author":"P Sangle","year":"2020","unstructured":"Sangle P, Sandhu O, Aftab Z, Anthony AT, Khan S. Vitamin B12 supplementation: preventing onset and improving prognosis of depression. Cureus. 2020;12(10):e11169e.","journal-title":"Cureus."},{"issue":"3","key":"282_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, H\u00e4user W, Katz RL, et al. 2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46(3):319\u201329.","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"282_CR21","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.3390\/nu12082221","volume":"12","author":"T Julian","year":"2020","unstructured":"Julian T, Syeed R, Glascow N, Angelopoulou E, Zis P. B12 as a treatment for peripheral neuropathic pain: a systematic review. Nutrients. 2020;12(8):2221.","journal-title":"Nutrients"},{"issue":"4","key":"282_CR22","doi-asserted-by":"publisher","first-page":"R120-R","DOI":"10.1186\/ar2783","volume":"11","author":"RM Bennett","year":"2009","unstructured":"Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120-R.","journal-title":"Arthritis Res Ther"},{"key":"282_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/1471-2458-9-341","volume":"9","author":"A Montazeri","year":"2009","unstructured":"Montazeri A, Vahdaninia M, Mousavi SJ, Omidvari S. The Iranian version of 12-item Short Form Health Survey (SF-12): factor structure, internal consistency and construct validity. BMC Public Health. 2009;9:341.","journal-title":"BMC Public Health"},{"issue":"5","key":"282_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/occmed\/kqu024","volume":"64","author":"AF Stern","year":"2014","unstructured":"Stern AF. The hospital anxiety and depression scale. Occup Med. 2014;64(5):393\u20134.","journal-title":"Occup Med"},{"issue":"4","key":"282_CR25","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","volume":"41","author":"F Faul","year":"2009","unstructured":"Faul F, Erdfelder E, Buchner A, Lang A-G. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods. 2009;41(4):1149\u201360.","journal-title":"Behav Res Methods"},{"issue":"5","key":"282_CR26","first-page":"848","volume":"38","author":"M Kikuchi","year":"1997","unstructured":"Kikuchi M, Kashii S, Honda Y, Tamura Y, Kaneda K, Akaike A. Protective effects of methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell culture. Invest Ophthalmol Vis Sci. 1997;38(5):848\u201354.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"282_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-2999(93)90925-8","volume":"241","author":"A Akinori","year":"1993","unstructured":"Akinori A, Yutaka T, Yuko S, Takeharu Y. Protective effects of a vitamin B12 analog, methylcobalamin, against glutamate cytotoxicity in cultured cortical neurons. Eur J Pharmacol. 1993;241(1):1\u20136.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"282_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s13311-017-0593-0","volume":"15","author":"J Gao","year":"2018","unstructured":"Gao J, Cahill CM, Huang X, Roffman JL, Lamon-Fava S, Fava M, et al. S-adenosyl methionine and transmethylation pathways in neuropsychiatric diseases throughout life. Neurotherapeutics. 2018;15(1):156\u201375.","journal-title":"Neurotherapeutics"},{"key":"282_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.14419\/ijbas.v5i4.6707","volume":"5","author":"R Justo","year":"2016","unstructured":"Justo R, Cesar M, Migowski E, Cisne de Paula R. Relation between vitamins of the b complex, GABA and glutamate, and their role in neurocognitive disorders -Brief review. Int J Basic Appl Sci. 2016;5:229.","journal-title":"Int J Basic Appl Sci"},{"issue":"2","key":"282_CR30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S1074-7427(02)00036-9","volume":"79","author":"L Cahill","year":"2003","unstructured":"Cahill L, Alkire MT. Epinephrine enhancement of human memory consolidation: interaction with arousal at encoding. Neurobiol Learn Mem. 2003;79(2):194\u20138.","journal-title":"Neurobiol Learn Mem"},{"issue":"4","key":"282_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3988\/jcn.2014.10.4.281","volume":"10","author":"R Ansari","year":"2014","unstructured":"Ansari R, Mahta A, Mallack E, Luo JJ. Hyperhomocysteinemia and neurologic disorders: a review. J Clin Neurol. 2014;10(4):281\u20138.","journal-title":"J Clin Neurol"},{"key":"282_CR32","doi-asserted-by":"publisher","first-page":"9968228","DOI":"10.1155\/2021\/9968228","volume":"2021","author":"S Baltrusch","year":"2021","unstructured":"Baltrusch S. The role of neurotropic B vitamins in nerve regeneration. Biomed Res Int. 2021;2021:9968228.","journal-title":"Biomed Res Int"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-022-00282-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-022-00282-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-022-00282-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T01:05:57Z","timestamp":1661994357000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-022-00282-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1186\/s41927-022-00282-y","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of Guilan University of Medical Sciences (IR.GUMS.REC.1400.197) in accordance with the World Medical Association\u2019s code of ethics (Declaration of Helsinki, revised in Brazil 2013), and registered at an ICMJE and WHO recognized registry of clinical trials () at 28\/08\/2021 (registration number: IRCT20200920048782N1). All participants were informed about the study design and then written informed consent was obtained from all volunteers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}